Navigation Links
Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
Date:3/25/2013

pe 2 diabetes. T2D is the most common type, accounting for an estimated 90 percent of all diabetes cases.[2] Diabetes is a chronic disease that occurs when the body either does not properly produce, or use, the hormone insulin.[4] Diabetes was estimated to cost the U.S. $245 billion in direct medical costs and reduced productivity in 2012.[5]

Boehringer Ingelheim and Eli Lilly and Company  
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on three pipeline compounds representing several of the largest treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsibly. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmen
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
2. Boehringer Ingelheim Cares Foundation Launches Online Giving Report
3. Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
4. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
5. Boehringer Ingelheim Selects ChemAxon to Power Next-Generation Global Cheminformatics Platform
6. FDA Advisory Committee Recommends Approval for Boehringer Ingelheims Olodaterol for Maintenance Treatment of COPD
7. Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems
8. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Boehringer Ingelheim Announces Equine Research Awards
11. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 /PRNewswire-iReach/ -- The Centers ... new five-state Quality Innovation Network-Quality Improvement Organization (QIN-QIO) contract ... Institute (WVMI). Effective August 1, WVMI will ... West Virginia , Pennsylvania , ... and Louisiana.  The Network will engage providers ...
(Date:7/23/2014)... , July 23, 2014 ... of the "Global Electrophysiology Ablation Catheters Market ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ... remove or destroy faulty electrical pathways from sections ... (also known as cardiac arrhythmias). Cardiac arrhythmias can ...
(Date:7/23/2014)... , July 23, 2014 Creekridge ... have added 14 new vendors so far in ... Creekridge,s newest vendors are from both the ... domestic organizations to large, well-known multi-national companies. Each ... diversified suite of financing products including: standard leasing ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Creekridge Capital Signs Several New Vendor Partners 2
... Experts from PAREXEL International Corporation (Nasdaq: PRXL ... best-practice strategic partnership models to increase operating efficiency and ... Clinical Trials conference, to be held March 30-April 1, ... how PAREXEL has transformed its business to ...
... 2011 The California Public Employees, Retirement System (CalPERS) ... renewing a contract awarded to Medco Health Solutions, Inc. ... services, the company said today.  The renewal was scheduled ... (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) The CalPERS contract has not ...
Cached Medicine Technology:PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 2PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 3PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 4CalPERS Notifies Medco of Renewal Decision 2
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes that can be ... now explored in a new guide posted at the Cherry ... over 30 are introduced in the guide as well as ... of creams as an alternative to surgery is one method ... the information in the new guide. Because there are hundreds ...
(Date:7/23/2014)... young adults living near Sellafield or Dounreay since the ... cancer according to research published in the British ... the Childhood Cancer Research Group at the University of ... 1963 and 2006 among those who were under 25 ... difference was found in cancer incidence from 1991-2006 between ...
(Date:7/23/2014)... scientist from the University of Exeter has developed ... diagnosing a frequently fatal lung disease which attacks ... bone marrow transplant recipients. , The lateral-flow device ... pulmonary aspergillosis, a notoriously difficult to diagnose disease ... , Invasive aspergillosis is a leading ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July 23, ... have been exposed to some form of childhood trauma than ... finding seems to apply solely to military men, not women. ... a cause for concern, given that early childhood exposure to ... civilian population has been linked to a higher adult risk ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July ... American children and teens look in the mirror and ... reported Wednesday. "Being overweight or obese is associated ... high cholesterol and diabetes," said lead researcher Neda Sarafrazi, ... Control and Prevention,s National Center for Health Statistics. ...
Breaking Medicine News(10 mins):Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:New device detects deadly lung disease 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3
... to begin studies about a vaccine that makes a person ... the name of the vaccine is undergoing trials, and if ... 2 years time. ,The vaccine targets the pleasure ... results in obliterating the urge to smoke. The vaccine is ...
... injury by maintaining Adenosine Tri Phosphate (ATP) levels in ... an antibiotic (used to trigger organ survival in transplant ... heart tissue damage after an acute heart attack might ... issue of the Journal of Molecular and Cellular Cardiology, ...
... at Stanford’s School of Medicine and Lucile Packard Children’s ... cause for mental retardation//in Down syndrome, in a gene ... normally, affecting attention, and memory. ,The researchers ... have identified a gene that, if over-produced, could cause ...
... Service suggests that reducing the dose of radiation for patients ... It is estimated that cancers caused by X-rays kill 780 ... said that many new devices that use X-rays to push ... sufficiently tested and their efficacy and safety remains unknown. ...
... For the first time in China, doctors have successfully ... a taboo on taking organs from people whom Chinese ... the first transplant with a heart extracted from a ... ethical significance," Chen Zhonghua, director of Institute of Organ ...
... cause diabetes in children and young adults, say scientists who ... people //with type 1 diabetes in Britain's Yorkshire county. ... any insulin to control levels of sugar in the blood, ... ,The researchers led by Dr Richard McNally from Leeds ...
Cached Medicine News:Health News:Antibiotic Proved Protective against Heart Tissue Damage and Cell Death – Research Find 2Health News:Stanford Researchers Identify A Gene Causing Downs Syndrome 2
... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...
... The Self-Cath family of ... patients a variety of ... Each catheter is ... grade PVC and has ...
IMMCO ANA Elisa meets the guidelines for the laboratory diagnosis and monitoring of systemic autoimmune rheumatic diseases intended for the use of clinical pathologists and laboratory physicians....
... is engineered to distribute contact pressure evenly over ... back, to maximize stability and patient comfort. ... readily conformable to patient anatomy, to provide a ... wool liner is standard on both units, as ...
Medicine Products: